About Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology
"La Sociedad de Lucha Contra el Cáncer del Ecuador es una Institución de derecho privado con finalidad social y sin fines de lucro. SOLCA Matriz Guayaquil y su Instituto Oncológico Nacional Dr. Juan Tanca Marengo constituye uno de los principales centros de prevención, diagnóstico, tratamiento y paliación de cáncer en la República del Ecuador, a éste, acuden pacientes de todo el territorio continental e insular."
Clinical Trials at Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology
During the past decade, Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology"
#1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology
According to Clinical.Site data, the most researched conditions in "Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology" are
"Breast Neoplasms" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology
Most popular intervention types in "Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (1 trials), "Herceptin" (1 trials), "Pertuzumab" (1 trials), "Placebo" (1 trials) and "Trastuzumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology
The vast majority of trials in "Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology" are
2 trials for "All" genders.
Clinical Trials Status at Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology
Currently, there are NaN active trials in "Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".